Covidien (COV) Tops Q2 EPS by 1c

July 26, 2012 7:15 AM EDT
Covidien (NYSE: COV) reported Q2 EPS of $1.07, $0.01 better than the analyst estimate of $1.06. Revenue for the quarter came in at $3.01 billion versus the consensus estimate of $3.01 billion.

For earnings history and earnings-related data on Covidien (COV) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings